Blue Persimmon advisors work across the medical product development ecosystem. We provide early-stage product value and program feasibility assessments across stakeholders.
We help patient advocacy organizations navigate the complexities of working with industry, regulatory authorities, and payer/HTA organizations. We guide organizations in patient-focused drug development (PFDD) strategies to get new and effective treatments for those who need them.
Blue Persimmon advisors work with industry on program evidence strategies, endpoint and clinical outcome assessment (COA) development research, and global development and commercialization strategies.
Blue Persimmon advisors establish the foundation needed to achieve your long-term objectives. Every Blue Persimmon assessment is unique and balances stakeholder needs with the practical realities of your organization.
Engagements include portfolio prioritization assessments, development strategies, organization structure/process strategies, resource requirement assessments, and stakeholder and evidence strategies.
Guided by your organization's culture and mission, we work collaboratively with you to develop impactful multi-year plans.
Blue Persimmon advisors develop evidence needed to improve health outcomes. Starting with the end in mind, we design and implement evidence strategies to:
Blue Persimmon advisors volunteer with scientific advisory committees, consortia, and non-profit boards. We advise individual research projects, guide organization leaders, and mentor students and interns.
Each year at least 20% of our time is dedicated to giving back. If we are unable to help, we will refer to our network of experts.
Copyright © 2023 Blue Persimmon Group LLC - All Rights Reserved.